There are case reports regarding the use of both anti-TNF agents and other biological drugs such as rituximab in SCD patients, and in general, the side-effect profile appears to be similar to that of patients without SCD [31–33]. This evidence concerns the gene TNF and Schnyder corneal dystrophy.